APDN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
APDN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Applied DNA Sciences's Issuance of Stock for the three months ended in Jun. 2024 was $10.81 Mil.
Applied DNA Sciences's Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2024 was $13.79 Mil.
The historical data trend for Applied DNA Sciences's Issuance of Stock can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied DNA Sciences Annual Data | |||||||||||||||||||||
Trend | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||||
Issuance of Stock | Get a 7-Day Free Trial | 2.87 | 10.64 | 13.76 | 14.43 | - |
Applied DNA Sciences Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Issuance of Stock | Get a 7-Day Free Trial | - | - | 0.05 | 2.94 | 10.81 |
A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Issuance of Stock for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.79 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Applied DNA Sciences's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.
Clay Shorrock | officer: Chief Legal Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Scott L Anchin | director | 16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127 |
William W Montgomery | 10 percent owner | 34211 SEAVEY LOOP RD., EUGENE OR 97405 |
Judith Murrah | officer: Chief Information Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Beth Jantzen | officer: Chief Financial Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Yacov A Shamash | director | |
Robert B Catell | director | 62 OSBORNE ROAD, GARDEN CITY NY 11530 |
John Iii Bitzer | director | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Joseph D. Ceccoli | director | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Elizabeth M. Ferguson | director | 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Charles S. Ryan | director | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
James A Hayward | director, officer: Chief Executive Officer | C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790 |
Karol Gray | officer: Chief Financial Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Ming-hwa Benjamin Liang | officer: Strategic Tech. Dev. Officer | C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790 |
Yacov Shamash | director | 100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200 |
From GuruFocus
By ACCESSWIRE • 09-17-2024
By ACCESSWIRE • 05-10-2024
By ACCESSWIRE • 07-29-2024
By ACCESSWIRE • 04-23-2024
By ACCESSWIRE • 09-04-2024
By ACCESSWIRE • 08-19-2024
By ACCESSWIRE • 06-05-2024
By GuruFocus News • 10-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.